Skip to Content
Healthcare Professionals

MRC/BAD/BSF Clinical Research Training Fellowship

MRC/BAD/BSF Clinical Research Training Fellowship

This is an MRC award which is in part funded by the BAD and BSF.  

You are encouraged to apply if: 

  • You would like to study for a three year PhD
  • You achieved your PhD more than five years ago but due to clinical training commitments you have not been able to do any research this award is available for post-doctoral funding

It is part of the highly prestigious MRC Clinical Research Training Fellowship (CRTF) scheme and the applicant goes through the MRC rigorous appraisal process.

The advantage of it being a joint award is that you have the support not only of the MRC but also the BAD the UKs national organisation for Dermatologists and the BSF which is the largest UK charity dedicated to advancing research in skin disease and skin biology. 

Follow the link here


Previous and current recipients of the MRC/BAD/BSF award are:


2010 Dr Andrew Pink, King's College London

Molecular genetic analysis of hidradenitis suppurativa


2010 Dr Angela Tewari, King's College, London

Induction and repair of UVA (340-400nm) induced cyclobutane dimers (CPD) in human skin in vivo and their biological consequences.


2012 Dr Rachael Jarrett, Oxford

The role of CD1a-restricted T cells in the pathogenesis of atopic eczema.


2013 Dr Satveer Mahil, King's College London

Regulation of keratinocyte innate immune genes by psoriasis susceptibility alleles.


2014 Dr Mieran Sethi, King's College London

Xeroderma pigmentosum: a model to study molecular, cellular and clinical consequences of specific defects in the nucleotide excision repair pathway.


2016 Dr Wisam Alwan, King's College London  

Investigating the role of Lactobacillus crispatus in healthy skin and psoriasis.


2017 Dr Teresa Tsakok, King's College London & St John's Institute of Dermatology

Clinical, genetic and immune determinants of drug immunogenicity in psoriasis.


2018 Dr Chuin Ying Ung, King's College London

The Role of Adipolin in Cutaneous Fibroproliferative Disease

Back to top